DEERFIELD, Ill., Feb. 15, 2011 /PRNewswire/ -- Takeda Pharmaceuticals International, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that its Pharmaceutical Development Division has entered into strategic partnerships with Covance (NYSE: CVD) and Quintiles, two of the world’s largest full-service contract research organizations.
Under terms of the agreements, Covance and Quintiles will work in close partnership with Takeda to plan and execute global development programs to support new compounds in all therapeutic areas, except oncology. Takeda will have access to the clinical development capabilities and central laboratory services of Covance and Quintiles, with each partner company providing dedicated resources to support Takeda’s development pipeline. Takeda intends to use a global program-level sourcing strategy to increase operational efficiency. Through these relationships, Takeda will move toward a fully virtual outsourcing model combining the expertise and capabilities of Takeda with those of Covance and Quintiles to improve productivity and facilitate Takeda’s global growth.
“Takeda is focused on growing its global drug development footprint, especially in Asia, while at the same time ensuring quality and increasing efficiency of our operations,” said Robert Ahlbrandt, Ph.D., senior vice president, global development operations for Takeda’s Pharmaceutical Development Division. “Our new strategic partnerships with Covance and Quintiles will improve the agility and productivity of our drug development activities, helping us to deliver innovative new medicines to patients globally.”
About Takeda Pharmaceuticals International, Inc.
Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the largest pharmaceutical company in Japan. Takeda Pharmaceuticals International, Inc. is the hub for R&D excellence and the commercial activities in Americas and Europe as well as other strategic functions of Takeda group. It is committed to maximize the global market potential of new products and the company’s international presence to realize Takeda’s Mission to strive toward better health for patients through leading innovation in medicine. Additional information about Takeda is available through its corporate Web site, www.takeda.com.
SOURCE Takeda Pharmaceuticals International, Inc.
RELATED LINKS http://www.takeda.com
